# DARPA Awards NRx $11M Clinical Trial Contract

On September 30, 2026, the Defense Advanced Research Projects Agency (DARPA) awarded NRx Defense Systems a **$11,177,757.27 prime contract** for the SPARC-TMS clinical trial. The study will evaluate single-day robotic transcranial magnetic stimulation combined with investigational drug NRX-101 for treatment-resistant depression, and patient enrollment is beginning. The award is already made, so it is not an open competition; any FDA-registration potential or use in military hospitals depends on trial results.

- The award positions NRx Defense Systems as the prime contractor responsible for executing the clinical trial; no contract number or solicitation opportunity is provided.
- Contractors and suppliers can assess whether their clinical research, treatment technology, or related services align with the trial’s execution needs, while recognizing that no follow-on procurement is announced.
- Organizations evaluating future defense-health opportunities should treat potential military-hospital expansion as contingent on trial outcomes, not as a confirmed requirement or award.

**Jurisdictions:** federal
**Industries:** Healthcare, Defense & Military
**Topics:** Grants & Funding
**Published:** September 30, 2026

### Government Entities
- Defense Advanced Research Projects Agency (DARPA)
- U.S. Food and Drug Administration (FDA)

### Vendors
- NRx Defense Systems (prime contractor and awardee)
- NRx Pharmaceuticals, Inc. (parent company)

### Key Quotes
> while success is far from guaranteed in any clinical trial, DARPA has a long track record of supporting pioneering efforts with far-reaching impact, and their support gives us the strongest possible foundation for success.
> — Joshua Brown, Chief Medical Innovation Officer, NRx Defense Systems

### Sources
- [$NRXP - NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression - https://t.co/5mdG0bGyXi](https://x.com/Zomo365j7o/status/2105251433008464381) - twitter-defense